Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Nvidia shares fall as it reportedly delays China AI chip designed to comply with U.S. export rules
Reuters, citing two sources familiar with the matter, reported that Nvidia told Chinese customers that it is delaying the launch of an AI chip that is designed to comply with U.S. export rules until the first quarter of next year. Post Views: 109
G7, Vietnam making final tweaks to climate plan ahead of COP28 – sources
Post Content Post Views: 107
Alibaba dips on MS downgrade as PDD grabs spot of most valuable Chinese e-commerce firm
Post Content Post Views: 133
Kotak Mahindra Bank sees stock price and P/B ratio decline, RoE and RoA improve
Post Content Post Views: 113
Indian government set to introduce rules against deepfake menace
Post Content Post Views: 104
European stock markets remain muted on Friday
Post Content Post Views: 114